immunology CRO
CASE STUDIES > Immunology Contract Research Organization
Immunology-CRO Nexus BioQuest seeking to expand into the US market
To grow their business in the US, Nexus BioQuest needed to engage the right biotech companies and decision-makers, at the right time.
The Challenge
Our client is a leading Contract Research Organization (CRO) with a specialization in preclinical research, particularly in the field of immunology. The company is renowned for its deep expertise in autoimmunity, inflammation, and immuno-oncology, providing high-quality, time-sensitive solutions for critical preclinical research.
​
They hired Outbound Pharma as they sought to expand operations into the US market, specifically focusing on California’s vibrant and competitive biotech sector. The company faced several challenges: (1) Limited visibility in a highly competitive market (2) Difficulty in establishing a strong presence in California’s dense biotech ecosystem (3) Navigating tight budgets due to reduced biotech investments.
The goal was to enhance visibility, establish credibility, and secure new US clients, leveraging their unique strengths.
​
​
The Solution
Outbound Pharma developed a comprehensive strategy to address these challenges:
​
-
Targeted Outreach: Implemented 25 email campaigns reaching over 1,500 decision-makers, highlighting our client’s unique offerings in immunology and rapid study initiation.
-
Conference Engagement: Focused 20% of the campaigns on attendees of key industry conferences in California, achieving a 75% open rate for these emails.
-
Emphasized client's Deep Immunology Expertise.
-
​Showcased their advanced capabilities and in-depth knowledge:
-
Rapid Study Initiation: Promoted their ability to start studies immediately and provide quick results.
-
Flexible Study Designs: Highlighted their ability to tailor study designs to specific research needs.
-
Efficient Project Management: Underlined their commitment to seamless communication and project management.
-
Local Networking: Utilized LinkedIn and conferences to connect with key influencers and decision-makers.
Lead Qualification: Targeted biotech and pharma companies with significant preclinical research budgets and immediate outsourcing needs.
The Results
Our targeted lead generation strategy delivered notable success:​
-
Campaigns Launched: 25
-
R&D leaders Contacted: Over 1,500
Key achievements included:
​​​
-
Rapid Project Start: Projects were initiated within 2 weeks from onboarding, with immediate study commencement and no delays.
-
Timely Deliverables: Downstream reporting was completed within two weeks, and expedited interim data options were provided.
-
Effective Communication: Achieved an average email open rate of 45%, with a remarkable 75% for conference-targeted emails.
Overall, the campaign resulted in 25 active engagements, more than 110 additional prospects, enhanced brand recognition, and strong client relationships, effectively establishing a significant presence in the targeted industry.
"Working with Outbound Pharma has been a valuable experience for Nexus BioQuest. Their well-structured onboarding process helped us refine our ICP and strengthen our value proposition, providing clear and actionable insights from the outset. The organisation and proactive communication throughout made collaboration seamless and efficient. I would recommend Outbound Pharma to any company looking to enhance their commercial strategy.!"
William Parish, CEO Nexus BioQuest